• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Femtech Startup Rosy Wellness Secures $2M for Women’s Sexual Health

by Jasmine Pennic 11/16/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Femtech Startup Rosy Wellness Secures $2M for Women's Sexual Health

What You Should Know: 

– Femtech startup Rosy Wellness, the app changing the sex lives of women across the country, announced today it raised an additional $2 million in seed funding led by Austin-based True Wealth Ventures with additional participation from Portfolia’s Femtech II Fund and Mindshift Capital. The company will use the funding to support further development of its flagship platform, grow the team, and facilitate original research in women’s sexual health. 

– Founder and CEO, Board-certified Ob/Gyn, Dr. Lyndsey Harper, M.D., FACOG, IF, started Rosy after recognizing that 43% of women had a sexual health problem but were met with a complete lack of resources when trying to solve these important issues. In 2019, Dr. Harper launched Rosy with the goal of putting sexual health education and tools in the hands of women everywhere. 

Recent Research

Recent studies validate Rosy’s approach and highlight how the company stands apart from other platforms in the space. In a 2020 study, results showed that Rosy users experienced statistically significant improvements in many aspects of sexual function including desire, arousal, orgasm, and lubrication. More recently, in a study from Mount Sinai Hospital presented at the American Urogynecology Society Annual Meeting, Dr. Alexandra Dubinskaya et al. concluded that “only one App was approved to be recommended to patients by experts in the field,” and that app was Rosy. This has been echoed in the medical community with more than 6% of ob/gyns in the country now recommending Rosy to their patients

“It’s time women feel empowered to talk about sexual health issues and have access to convenient solutions,” said Dr. Harper. “I created Rosy to revolutionize the way women and their providers think about, talk about, and treat women’s sexual problems.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Femtech

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |